DXCM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Dexcom Inc (DXCM) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company has shown strong financial performance and positive long-term growth potential, the current technical indicators and trading sentiment suggest a neutral to slightly bearish short-term outlook. Waiting for a better entry point or further confirmation of positive momentum would be prudent.
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is at 31.554, close to oversold but still neutral. The stock is trading near support levels (S1: 71.121, S2: 70.164) but has not shown signs of reversal. Moving averages are converging, suggesting indecision in the market.
Strong financial performance in Q4 2025, with revenue up 13.12% YoY, net income up 76.20% YoY, and EPS up 81.08% YoY. Analysts have raised price targets recently, with most maintaining positive ratings. The company continues to innovate with its G7 glucose sensor, which is expected to drive growth.
The stock has declined 3.03% in regular trading, with bearish technical indicators. Options sentiment is bearish, and there is no recent news to act as a positive catalyst. The stock has a 70% chance of declining 1.61% in the next day and only a modest 0.28% gain in the next week.
Dexcom reported strong Q4 2025 financials, with revenue increasing to $1.2596 billion (up 13.12% YoY), net income rising to $267.3 million (up 76.20% YoY), EPS increasing to $0.67 (up 81.08% YoY), and gross margin improving to 70.3% (up 10.36% YoY). These results highlight robust growth and operational efficiency.
Analysts are generally positive on Dexcom, with recent price target increases from Mizuho ($90), Baird ($87), and Bernstein ($86), all maintaining Outperform ratings. However, Barclays has an Underweight rating with a $72 price target, reflecting some divergence in sentiment. The consensus view is favorable, but not overwhelmingly bullish.
